Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global viral vector manufacturing market size was valued at USD 2.60 Billion in 2024, with Europe holding a significant market share. The market is driven by advancements in gene therapy and vaccine development. It is expected to grow at a CAGR of 19.74% during the forecast period of 2025-2034, with the values likely to attain USD 15.75 Billion by 2034.
Base Year
Historical Period
Forecast Period
According to the Alliance for Regenerative Medicine, around 358 gene therapy trials were reported in Europe in 2023, with the total investment in gene therapy estimated to be USD 1.2 billion in the year. The rising focus on gene therapy to treat various diseases is expected to directly impact the market demand.
The key market players are actively investing in the capacity expansion of their production facilities which is likely to boost Europe viral vector manufacturing market share in coming years. In June 2023, Yposkesi, the viral vector manufacturing subsidiary of SK pharmteco’s (a CDMO) in France, completed its second facility for the manufacture of cell and gene therapies.
A major market trend is the rise in strategic partnerships between the leading biotechnology companies and contract development and manufacturing organizations (CDMOs). In December 2023, Oxford Biomedica entered into an agreement to acquire ABL Europe S.A.S. from Institut Mérieux SA.
The global viral vector manufacturing market was valued at USD 2.6 billion in 2023, with Europe holding a significant market share. The market is driven by advancements in gene therapy and vaccine development. It is expected to grow at a CAGR of 19.74% during the forecast period of 2024-2032, with the values likely to attain USD 13.5 billion by 2032.
Viral Vector Manufacturing Market Size
Viral Vector Manufacturing Market Analysis
Viral Vector Manufacturing Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The Europe viral vector manufacturing market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 19.74% during the forecast period of 2025-2034 and is likely to reach a market value of USD 15.75 Billion by 2034.
The increasing focus on gene therapy and vaccine development is fuelling the demand for the market.
One of the significant trends in the market is the rise in strategic partnerships between the leading biotechnology companies and contract development and manufacturing organizations (CDMOs). In December 2023 , Oxford Biomedica entered into an agreement to acquire ABL Europe S.A.S. from Institut Mérieux SA. The acquisition will strengthen the company’s position as the leading cell and gene therapy CDMO.
Based on the type, the market is segmented into adenoviral vectors, adeno-associated viral (AAV) vectors, lentiviral vectors, and retroviral vectors, among others.
By therapeutic area, the market is divided into oncological disorders, neurological disorders, metabolic disorders, and immunological disorders, among others.
End users of the market are research organizations, biotech, and pharmaceutical companies, among others.
Major applications of viral vector manufacturing include gene therapy, cell therapy, and vaccines.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy, among others.
The key players in the market are Lonza Group AG, Merck KGaA, Oxford Biomedica, Novartis AG, Sartorius AG, SIRON Biotech, PlasmidFactory GmbH, Kaneka Eurogentec S.A., Advanced BioScience Laboratories, Inc., and F. Hoffmann-La Roche AG.
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124